Zhejiang Huahai Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600521.SS

Zhejiang Huahai Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2023: 4.46%

Zhejiang Huahai Pharmaceutical Co., Ltd. Return on Assets (ROA) is 4.46% for the year ending December 31, 2023, a -30.60% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Zhejiang Huahai Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was 6.43%, a 104.11% change year over year.
Zhejiang Huahai Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was 3.15%, a -55.96% change year over year.
Zhejiang Huahai Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was 7.16%, a 34.82% change year over year.
Zhejiang Huahai Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was 5.31%, a 411.92% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Shanghai Stock Exchange: 600521.SS

Zhejiang Huahai Pharmaceutical Co., Ltd.

CEO	Mr. Bao Hua Chen
IPO Date	March 4, 2003
Location	China
Headquarters	Xunqiao
Employees	8,221
Sector	Health Care
Industries Pharmaceuticals

Description

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.

Key trends

Past 5 years